Dr. Paula Deming’s research focuses on understanding molecular and cellular alterations that occur in cancer.

One project investigates the alterations of a gene associated with lung cancer, the leading cause of worldwide cancer-related mortality. In the Deming Laboratory, undergraduate and graduate students collaborate on characterizing the clinical impact of genetic variants in the STK11 gene identified in tumor samples from patients seen at the UVM Medical Center. Genomic testing on tumor samples can help to tailor the course of clinical treatment and supply prognostic information for cancer patients and their clinicians. Learn more >>